Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. clinical trials

A subsidiary of Sino Biopharmaceutical Limited

The registry lists 2 studies whose lead sponsor is Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 27, 2026.

Status

Terminated: 1
Not yet recruiting: 1

Phase

Phase 1: 2

Where

China: 2

Registry sponsor names on this page

Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.2 studies

Something wrong with this grouping? Tell us on the Sino Biopharmaceutical Limited page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Sino Biopharmaceutical Limited studies →

A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant TumorsNot yet recruitingNCT06649656Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult SubjectsTerminatedNCT07267130Phase 1
Sponsor listed in the registry: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.